Biologics at CPI – A snapshot of CR&D Projects

The Biologics team at CPI currently have several projects in progress with many more on the way. Here is a snapshot of recently funded CR&D projects:

Share This Page

Harnessing UK innovation to streamline the biologics supply chain from molecule to medicine Partners: UCB, Lonza, Sphere Fluidics, Alcyomics & Horizon Discovery

Nanofacturing – the development of medium and large-scale sustainable manufacturing process platforms for clinically compliant solid core nanopharmaceuticals Partners: Midatech Pharma, GalChimia, ProChimia Surfaces, Applus Laboratories, Centre For BioNano Interactions, National University of Ireland – Dublin, Istituto Firc Di Oncologia Molecolare, Ecole Polytechnique Fédérale de Lausanne

Combinatorial genome editing to create enhanced biomanufacturing platforms Partners: Horizon Discovery & University of Manchester

Improved downstream operation through formulation innovation Partners: Arecor & FUJIFILM Diosynth Biotechnologies

Improving the therapeutic window of glycosylated drug classes and the development of a novel and rapid high throughput analytical methodology to streamline the drug development pathway Partners: Glythera & GlycoSeLect

UK Continuous, integrated biologics manufacturing project Partners: Pall UK, GSK, MedImmune, FUJIFILM Diosynth Biotechnologies, Allergan Biologics UK, Merck Sharpe Dohme UK, Sciex UK Ltd

Developing regenerative medicines & cell therapies – development of an industrial manufacturing platform for adeno-associated virus (AAV) production to support regenerative gene therapy products Partners: Cobra Biologics